BB
Schedule 13D filing
BAKER BROS. ADVISORS LP disclosed a 7.8% stake in BeOne Medicines Ltd. (ONC)
BAKER BROS. ADVISORS LP reported owning 7.8% of BeOne Medicines Ltd. (ONC) (115,912,814 shares) in a Schedule 13D filed Sep 16, 2026.
A 13D means the holder may push for changes at the company.
More ONC insider and Congress trades
From a public Schedule 13D, linked above. Not investment advice, and not a recommendation to buy or sell.